undamentalytics Newsletter

Azitra, Inc. key statistics and ratios

In fiscal 2024, Azitra, Inc. had an operating margin of -146468.5%, debt equal to 0.0% of equity and a current ratio of 3.80. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Azitra, Inc.: financial ratios, annual
Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Operating margin<−999%<−999%<−999%—
Net margin<−999%<−999%<−999%—
Free-cash-flow margin<−999%<−999%<−999%—
Return on assets−149.0%−183.7%−143.8%−176.9%
Asset turnover0.040.110.00—
Current ratio1.861.583.802.83
Debt to equity——0.0%0.0%
Interest cover (operating income ÷ interest)n/mn/mn/mn/m
R&D as % of revenue>999%531.1%>999%—
Capital spending as % of revenue11.7%3.9%114.3%—

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: AZTR vs CELZAZTR vs LYELAIM vs AZTR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Azitra, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Azitra, Inc.